We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Series of Lab-on-a-Chip Assays

By Biotechdaily staff writers
Posted on 14 Mar 2006
Eighteen new or upgraded assay kits for RNA, DNA, and protein have been developed that offer improved sensitivity, sizing range, robustness, and sample matrix tolerance. More...


The Series II family of assay kits is designed for use with the Agilent 2100 bioanalyzer platform of Agilent Technologies (Palo Alto, CA, USA). In addition to improved specifications, the new kits have an extended shelf-life of a minimum of four months, which is expected to grow with further testing. There will be no need to purchase separate ladders for the RNA assay. The existing kits will be phased out by June 2006.

The Series II protein assays facilitate the replacement of time-consuming sodium dodecyl (lauryl) sulphate-polyacrylamide gel (SDS-PAGE) and capillary gel electrophoresis with much faster fluidic analyses. The Protein 230 kit features an increased sizing range, higher sensitivity and salt tolerance. The Protein 80 kit can be used for analyzing proteins from 5-80 kDa, making it suitable for reduced antibodies. Primary improvements to the three DNA Series II assays include better sizing and quantification, better sensitivity specifications, increased stability and robustness, and streamlined protocol. The RNA and protein kits are boxed in two parts for storage at 4 or -20ºC.



Related Links:
Agilent Technologies

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Manual Pipetting Aid
Pipette Controllers macro
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.